Literature DB >> 11436040

Modified Glenn connection for acutely ischemic right ventricular failure reverses secondary left ventricular dysfunction.

M H Danton1, J G Byrne, K Q Flores, M Hsin, J S Martin, R G Laurence, L H Cohn, L Aklog.   

Abstract

BACKGROUND: Right heart failure after cardiopulmonary bypass can result in severe hemodynamic compromise with high mortality, but the underlying mechanisms remain poorly understood. After ischemia-induced right ventricular failure, alterations in the interventricular septal position decrease left ventricular compliance and limit filling but may also distort left ventricular geometry and compromise contractility and relaxation. This study investigated the effect of acute isolated right ventricular ischemia on biventricular performance and interaction and the response of subsequent right ventricular unloading by use of a modified Glenn shunt.
METHODS: In 8 pigs isolated right ventricular ischemic failure was induced by means of selective coronary ligation. A modified Glenn circuit was then established by a superior vena cava-pulmonary artery connection. Ventricular performance was determined by conductance catheter-derived right ventricular pressure-volume loops and left ventricular pressure-segment length loops. Hemodynamic data at baseline, after right ventricular ischemia, and after institution of the Glenn circuit were obtained during inflow occlusion, and the load-independent contractile indices were derived.
RESULTS: Right ventricular free-wall ischemia resulted in acute right ventricular dilation (118 +/- 81 mL vs 169 +/- 70 mL, P =.0008) and impairment of left ventricular contractility indicated by the reduced end-systolic pressure-volume relation slope (50.0 +/- 19 mm Hg/mm vs 18.9 +/- 8 mm Hg/mm, P =.002) and preload recruitable stroke work index slope (69.6 +/- 26 erg x cm(-3) x 10(3) vs 39.7 +/- 13 erg x cm(-3) x 10(3), P =.003). In addition, left ventricular relaxation (tau) was significantly prolonged (33.3 +/- 10 ms vs 53.0 +/- 16 ms, P =.012). Right ventricular unloading with the Glenn shunt reduced right ventricular dilation and significantly improved left ventricular contraction, end-systolic pressure-volume relation slope (18.9 +/- 8 mm Hg/mm vs 35.8 +/- 18 mm Hg/mm, P =.002), preload recruitable stroke work index slope (39.7 +/- 26 erg x cm(-3) x 10(3) vs 63.0 +/- 22 erg x cm(-3) x 10(3), P =.003), and diastolic performance (tau 53.0 +/- 16 ms vs 43.5 +/- 13 ms, P =.001).
CONCLUSIONS: Right ventricular ischemia-induced dilation resulted in acute impairment of left ventricular contractility and relaxation. A modified Glenn shunt attenuated the left ventricular dysfunction by limiting right ventricular dilation and restoring left ventricular cavity geometry.

Entities:  

Mesh:

Year:  2001        PMID: 11436040     DOI: 10.1067/mtc.2001.114632

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  A modified Glenn shunt reduces venous congestion during acute right ventricular failure due to pulmonary banding: a randomized experimental study.

Authors:  Per Vikholm; Petter Schiller; Laila Hellgren
Journal:  Interact Cardiovasc Thorac Surg       Date:  2014-01-06

Review 2.  The Dark Side of the Moon: The Right Ventricle.

Authors:  Massimiliano Foschi; Michele Di Mauro; Fabrizio Tancredi; Carlo Capparuccia; Renata Petroni; Luigi Leonzio; Silvio Romano; Sabina Gallina; Maria Penco; Mario Cibelli; Antonio Calafiore
Journal:  J Cardiovasc Dev Dis       Date:  2017-10-20

Review 3.  Cardioprotection in right heart failure.

Authors:  Kerstin Boengler; Klaus-Dieter Schlüter; Ralph Theo Schermuly; Rainer Schulz
Journal:  Br J Pharmacol       Date:  2020-03-09       Impact factor: 8.739

4.  Hemi-fontan or bidirectional cavopulmonary shunt for right ventricular failure after mitral valve replacement and acute ascending aortic dissection: report of two cases.

Authors:  Hassan Teimouri; Feridoun Sabzi; Babak Nasiri
Journal:  J Tehran Heart Cent       Date:  2013-04-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.